Search Results - "Waraya, M"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation by Shimozato, O, Waraya, M, Nakashima, K, Souda, H, Takiguchi, N, Yamamoto, H, Takenobu, H, Uehara, H, Ikeda, E, Matsushita, S, Kubo, N, Nakagawara, A, Ozaki, T, Kamijo, T

    Published in Oncogene (09-04-2015)
    “…Although CD133 has been considered to be a molecular marker for cancer stem cells, its functional roles in tumorigenesis remain unclear. We here examined the…”
    Get full text
    Journal Article
  2. 2

    Receptor-type protein tyrosine phosphatase [kappa] directly dephosphorylates CD133 and regulates downstream AKT activation by Shimozato, O, Waraya, M, Nakashima, K, Souda, H, Takiguchi, N, Yamamoto, H, Takenobu, H, Uehara, H, Ikeda, E, Matsushita, S, Kubo, N, Nakagawara, A, Ozaki, T, Kamijo, T

    Published in Oncogene (09-04-2015)
    “…Although CD133 has been considered to be a molecular marker for cancer stem cells, its functional roles in tumorigenesis remain unclear. We here examined the…”
    Get full text
    Journal Article
  3. 3

    Epigenetic Silencing of HOPX Promotes Cancer Progression in Colorectal Cancer by Katoh, Hiroshi, Yamashita, Keishi, Waraya, Mina, Margalit, Ofer, Ooki, Akira, Tamaki, Hideaki, Sakagami, Hiroyuki, Kokubo, Kenichi, Sidransky, David, Watanabe, Masahiko

    Published in Neoplasia (New York, N.Y.) (01-07-2012)
    “…Abstract Homeodomain-only protein X (HOPX)-β promoter methylation was recently shown to be frequent in human cancers and was suggested as tumor suppressor gene…”
    Get full text
    Journal Article
  4. 4

    Abstract P3-09-03: Final result of randomised controlled phase II study of the efficiency of palonosetron, aprepitant, and dexamethasone for day1 with or without dexamethasone on days2 and 3 by Kosaka, Y, Sengoku, N, Minatani, N, Kikuchi, M, Nishimiya, H, Waraya, M, Enomoto, T, Kuranami, M, Tanino, H, Watanabe, M

    Published in Cancer research (Chicago, Ill.) (15-12-2013)
    “…Abstract Background: Emesis is one of the major non-hematologic toxicity caused by chemotherapy. The control of Chemotherapy Induced Nausea and Vomiting (CINV)…”
    Get full text
    Journal Article